Hematological Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Octagam 10% Approved

The FDA has approved Octagam 10% liquid preparation for the treatment of adults with chronic immune thrombocytopenic purpura (ITP).

Hem B Prophylaxis: Positive Results

Pfizer announced positive results of a Phase 3 study comparing BeneFIX Coagulation Factor IX (Recombinant) to on-demand treatment.

Ruconest Approved

the FDA has approved Ruconest for the treatment of acute angioedema attacks in adult and adolescent patients with hereditary angioedema (HAE).

Zydelig Approved for Blood Cancer

The FDA has approved Zydelig (idelalisib) in combination with rituximab for patients with relapsed chronic lymphocytic leukemia.

Hematological Reference Values

Review this chart on 'Hematological Reference Values' for quick information when you need it.

First Gene-Based Test for Transfusion

The first molecular assay used in transfusion medicine to determine blood compatibility has been approved by the FDA.

New Drug Product: Alprolix

Prevention and control of bleeding in hemophilia B.

Generic Cyklokapron Injection Approved

Acella announced the approval of an Abbreviated New Drug Application for Tranexamic Acid Injection, the generic version of Pfizer's Cyklokapron.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Vertebroplasty is effective for managing myelomatous VCFsExternal web site

Nurse awareness of this treatment option and the patient selection criteria may be a significant ...

CE 0.60 Credits

Transformative Changes in the Management of Multiple MyelomaExternal web site

This symposium will address practical applications of an individualized approach to management of patients with ...

CME 0.50 Credits

Sign Up for Free e-newsletters